OR WAIT 15 SECS
Increases global capacity and adds new secondary packaging and labeling services to more efficiently deliver clinical trial supplies
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company’s facilities in Billerica, Mass., will help PAREXEL more effectively manage clients’ global clinical trial supply requirements.
PAREXEL’s Clinical Logistics Services provides synchronized coordination of clinical trial supplies, central lab services, and ancillary supplies worldwide to ensure safe and timely distribution. The Company offers risk evaluation and mitigation planning for in-time-investigational-site supply, as well as expertise in global import/export compliance. New capabilities include secondary packaging and labeling services. The facility expansion builds upon PAREXEL’s considerable global clinical logistics infrastructure in North America, Latin America, Europe, Africa and the Asia/Pacific region.
“As clinical trials increase in size and complexity, clients are challenged to develop and implement strategies that create consistent sourcing, manufacturing, storage and distribution processes along the supply chain,” said Mark A. Goldberg, President and Chief Operating Officer, PAREXEL. “Our investments in these important distribution centers and depots are part of the Company’s ongoing efforts to simplify the clinical trial journey for biopharmaceutical clients by supporting their growing global supply and logistics needs.”
PAREXEL’s clinical logistics facilities offer sophisticated capabilities that include enhanced expiry and update labeling services. These services eliminate the need to return supplies to the manufacturing organization, reduce study start-up time and help ensure timely first-patient-in milestones. Additional capabilities include a distribution and warehousing infrastructure to manage and transport clinical trial supplies to locations worldwide, as well as leading technology systems that track and trace shipments and manage inventory levels.
“PAREXEL continues to build a global network of storage and distribution facilities with harmonized configurations that provide a consistent and reliable flow of materials needed in the clinical trial process,” said Kurt Norris, Corporate Vice President, Clinical Logistics Services, PAREXEL. “This reflects our commitment to provide leading-edge management of clinical trial materials to clients across the globe.”